曲美他嗪治疗缺血性心脏病心力衰竭的效果观察被引量：6

导出

摘要目的观察曲美他嗪治疗缺血性心脏病心力衰竭的效果。方法 84例缺血性心脏病心力衰竭患者按入选前后顺序分为两组,均使用血管紧张素转移酶抑制剂(ACEI)、β受体阻滞剂、利尿剂、硝酸酯类治疗。治疗组42例,加用曲美他嗪20mg,2次/d,共6个月。观察两组心脏功能及结构变化。结果治疗6个月后,治疗组心功能明显改变,总有效率达95.2%,而对照组为71.4%,治疗组疗效好于对照组(P<0.05),左室射血分数(LVEF)、E/A比值均比对照组增加,左心室收缩末期内径(LVSD)、左心室舒张末期内径(LVDD)明显下降(P均<0.05)。结论曲美他嗪能有效改善缺血性心脏病心力衰竭患者的心脏收缩及舒张功能,提高生活质量,耐受性好。

作者韦宗文

机构地区广西宜州市人民医院

出处《广西医学》 CAS 2010年第4期437-438,共2页 Guangxi Medical Journal

关键词缺血性心脏病曲美他嗪心力衰竭

分类号 R541.61 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献5

1詹小娜.曲美他嗪对缺血性心肌病左室功能的疗效观察[J].中国医刊,2007,42(11):53-54. 被引量：9
2李静,朱永锋,刘媛媛,黎莉.曲美他嗪对老年冠心病心力衰竭患者左室功能的影响[J].山东医药,2009,49(41):44-45. 被引量：13
3严俊儒,辜和平,张耿新,史旭波,许俊堂,安彬.曲美他嗪治疗稳定性劳力型心绞痛疗效及耐受性的观察[J].中国医刊,2003,38(8):35-37. 被引量：12
4Jackson G.The place of metabolic agents in the management of stable angina pectoris[J].Rev Port Cardiol,1999,18(Suppl 4):23-27.
5杨顺昱.曲美他嗪治疗缺血性心肌病心力衰竭37例疗效观察[J].广西医学,2007,29(6):835-836. 被引量：4

二级参考文献20

1赵玉娟,傅世英,周立君,寇俊杰,李为民.缺血性心肌病心力衰竭患者心脏收缩和舒张功能及其再住院率与曲美他嗪的干预效应[J].中国临床康复,2005,9(23):74-75. 被引量：6
2陈灏珠,主编.实用内科学[M] 第12版.北京:人民卫生出版社,2005.1 579-1 582.
3Nomenclature and criteria for diagnosis of ischernic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature[J]. Circulation, 1979, 59(3) :607-609.
4Kantor PF, Lueien A, Kozak R, et al. The antianginal drug trimetasidine shifts cardiac energymetabolism from fatty aeidoxidation to glucose oxidation by inhibiting mitoehondfial long-chain 3-ketoacyl coenzyme a thiolase[J]. Circ Res,2000, 86(2) :580-588.
5Lopaschuk GD, Barr R, Thomas PD, et al. Beneficial effects of trimetazidine invivo working ischemic hearts are due to a stimulation of glucose oxidation secondary, to inhibition of long-chain 3-ketoacyl coenzyme a thiolase[J]. Circ Res, 2003, 93(3) :E33-37.
6Sentex E, Helies-Tussaint C, Rousseau D, et al. Influence of trime-tazidine on the synthesis of complex lipids in the heart and other target organs[J]. Fundam Clin Pharmaeol, 2001, 15:255-264.
7Kay L, Finelli C, Aussedat J, et al. Improvement of long term preservation of the isolated arrested rat heart by trimctazidine: effects of the energy, state and mitochondrial function [ J ]. Am J Cardiol, 1995,76(6) :45B-49B.
8Cristiana Vitale, Mauricio Waingaten, Barbara, et al. Tfimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery diseases[J]. Eur Heart, 2004,25(20) : 1765-1768.
9[1]Cross HR. Trimetazidine fors table angina pectoris. Expert Opin Pharma cother,2001,2:857 - 75
10[2]Reymond F,Steyaert G,Carrupt P,et al. The pH-partition profile of the anti-ischemic drug trimetazidine may explain its reduction of intracellular acidosis. Pharmaceutical Res, 1999,16:616 - 624